Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa Effect on Autonomic Function in Parkinson's Disease
NCT05487300Phase 3Completed
- Sponsor
- University of Utah
- Start
- May 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levodopa in Parkinson's disease (PD), sponsored by University of Utah. Started May 2022; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05487300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05487300.